Drug Safety Information for ULTRAM (Tramadol hydrochloride)
REMS for TRAMADOL (TRAMADOL HYDROCHLORIDE) Rx Drug: FDA Link
Shared FDA Risk Evaluation and Mitigation Strategy
Safety-related Labeling Changes for ULTRAM (TRAMADOL HYDROCHLORIDE) Rx Drug: FDA Link
Safety-related Labeling Changes for ULTRAM ER (TRAMADOL HYDROCHLORIDE) Rx Drug: FDA Link
Safety-related Labeling Changes for CONZIP (TRAMADOL HYDROCHLORIDE) Rx Drug: FDA Link
Adverse Drug Reactions for ULTRAM* (Tramadol hydrochloride)
These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).
Top 20 Adverse Effects Associated with ULTRAM
(reported in FDA Medwatch/FAERS Reports)
Side Effect | # of FDA Reports | |
---|---|---|
1 | Nausea* | 3941 |
2 | Pain | 3569 |
3 | Drug ineffective | 3055 |
4 | Vomiting | 2907 |
5 | Headache* | 2875 |
6 | Fatigue | 2792 |
7 | Dyspnoea | 2763 |
8 | Dizziness* | 2502 |
9 | Diarrhoea | 2392 |
10 | Fall | 2216 |
11 | Arthralgia | 2145 |
12 | Asthenia | 2028 |
13 | Toxicity to various agents | 1960 |
14 | Drug interaction | 1944 |
15 | Pain in extremity | 1857 |
16 | Malaise | 1769 |
17 | Anxiety* | 1761 |
18 | Depression | 1750 |
19 | Confusional state | 1714 |
20 | Pyrexia | 1705 |
* This side effect also appears in "Top 10 Side Effects of ULTRAM " in the drug's Review Summary based on AskaPatient reviews.
Top 10 Reasons for Taking ULTRAM
(associated with FDA Medwatch/FAERS Reports)
Reason | # of FDA Reports | |
---|---|---|
1 | Product used for unknown indication | 43223 |
2 | Pain* | 40143 |
3 | Back pain* | 7082 |
4 | Analgesic therapy | 3633 |
5 | Arthralgia | 3291 |
6 | Arthritis* | 1783 |
7 | Rheumatoid arthritis* | 1782 |
8 | Fibromyalgia* | 1739 |
9 | Headache | 1352 |
10 | Osteoarthritis | 1316 |
*Also a top-10 reason in AskaPatient Review Summary.
Types of Adverse Events for ULTRAM
Total Reports Filed with FDA: 289479
Number of FDA Adverse Event Reports by Patient Age for ULTRAM
Total Reports Filed with FDA: 289479*
* Reports for drugs with the same active ingredients have been aggregated in this analysis: Tramadol hydrochloride (Topalgic, Tramadol ratiopharm, Tramadol hcl, Tramadol, Tramadin, Tradol, Tramagit, Zytram, Biodalgic, Tradonal, Tramadura, Zydol, Conzip, Rybix odt, Tramal, Tramadol er, Zamudol, Ultram er, Tramundin, Tramadoc, Tramadolor, Rybix, Amadol, Zamadol, Contramal, Tramagetic, Zydol sr, Takadol, Prontofort, Tramadol normon, Tramabeta, Tramake, Tralgiol, Adolonta, Ryzolt, Nobligan, Ultram)
Charts are based on 289479 reports filed with the FDA between 2004 and June 2015.
Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.
Click to go back to search results and ULTRAM Reviews and Review Summary .
Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.